SEC Tracker
Get the app

Collegium Pharmaceutical COLL

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

Form
8-K
Filed
Importance
Notable
  • Signs a material agreement (1.01)
  • Reports quarterly results (2.02)
  • Takes on a new financial obligation (2.03)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Collegium Pharmaceutical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. CorMedix CRMD public float $910M, Jun 30, 2025
  2. Geron GERN public float $861M, Jun 30, 2025
  3. Harrow HROW public float $1.0B, Jun 30, 2025
  4. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025
  5. Phibro Animal Health PAHC public float $764M, Dec 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.